RESMED INC — Director's Dealing 2020

Nov 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-11

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-11	ResMed Common Stock	F	3417	$212.11	Disposed	364878	Direct
2020-11-11	ResMed Common Stock	F	2973	$212.11	Disposed	361905	Direct
2020-11-11	ResMed Common Stock	F	2221	$212.11	Disposed	359684	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	8970	Indirect

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.

F2: Includes 121.68 shares of ResMed stock purchased on October 31, 2020, through the ResMed Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.

F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.